About OrbitalRX
OrbitalRX is a Healthcare company based in Winston-salem (United States) founded in 2017. Provider of an online platform for pharmacists to manage drug shortages and supply chain management. OrbitalRX has raised $5.89 million across 6 funding rounds from investors including The Launch Place. OrbitalRX offers products and services including Shortage Manager, ShortScore, and OrbitalRX Platform. Its focus areas include HealthTech, Pharmacy IT, Supply Chain Management and Inventory Management. Its competitors include Lumere and Aesynt; 1 of its 2 listed competitors has raised funding.
Company details
OrbitalRX (previously known as Arxchitect) provides drug shortage management solutions. It provides tools to hospitals and pharmacies to address medication shortages and responding to supply chain threats. The platform allows the users to access drug information such as the drug stock in the inventory, automated storage inventory, and customizable labeling solutions. The inbuilt dashboard provides access to the information of the inventory and also assists with the communication system.
- Headquarters Winston-salem, United States
- SectorsHealthcare
- Phone•••• ••••
- Website orbitalrx.com
- Social LinkedIn X
- Total Equity Funding$5.89M (USD)
in 6 rounds
- Latest Funding Round$1.22M (USD), Series A
Aug 2025
- Investors
Products & Services of OrbitalRX
OrbitalRX offers a comprehensive portfolio of products and services, including Shortage Manager, ShortScore, and OrbitalRX Platform.
Tool for unifying data and managing drug shortages in hospitals.
System for scoring and analyzing drug shortages efficiently.
Platform providing real-time insights for proactive shortage management.
Funding Insights of OrbitalRX
OrbitalRX has successfully raised a total of $5.89M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $1.22 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.89M
- Total Rounds 6
- Last Round Series A — $1.22M
- First Round $2.15M
(Aug 2019)
- Investors Count 1
All 6 funding rounds of OrbitalRX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2025 | $1.22M | Series A | – | – | – |
| Jan 2025 | $958,932 | Series A | – | – | – |
| May 2023 | $1.41M | Series A | – | – | – |
| Mar 2021 | $150,000 | Seed | – | The Launch Place | – |
| Mar 2020 | $733,481 | Debt – Conventional | – | – | – |
| Aug 2019 | $2.15M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in OrbitalRX
OrbitalRX has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Launch Place.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
The Launch Place is engaged in supporting startups through funding and mentoring. | thelaunchplace.org | Danville, United States |
Investor details for OrbitalRX
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of OrbitalRX
5 people are tracked at OrbitalRX (3 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Krysten Zavistoski | Director Of Product Management | Leadership |
Nate Peaty | Chief Strategy Officer & Founder | Leadership |
Nate Peaty, PharmD | Founder + Chief Product Officer | Leadership |
Madeline👩🏼💻 Hassett | Senior Frontend Software Engineer | Team |
Mattie Whitmore | Senior Principal Engineer at OrbitalRX | Team |
Complete people profiles for OrbitalRX
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OrbitalRX
3 dated milestones of OrbitalRX across 8 years, from founding to its latest funding, stage changes and deals.
- Founded OrbitalRX is founded.
- Funding First funding round of $2.1M.
- Funding Latest funding round, Series A, of $1.2M.
Competitors of OrbitalRX
OrbitalRX has 2 listed competitors in our database, 1 of them funded. They include Lumere and Aesynt.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lumere.com | 2012 | Chicago, United States | $21.18M | 212 | Provider of supply chain management and formulary management for pharmacies and healthcare organizations | |
| aesynt.com | 2013 | Cranberry Township, United States | 746 | Provides pharmacy automation and information management solutions for hospitals and health systems. |
Detailed competitors of OrbitalRX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmacy & Healthcare Retail Systems
3 companies that operate in the same segment as OrbitalRX (Pharmacy & Healthcare Retail Systems) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | 802 | ||
Optum is recognized as a leading health solution and care delivery organization. | 2011 | Eden Prairie, Minnesota, United States | USD 250 K | USD 383.36 M | 140 | |
Materials management and business analytics solutions for healthcare are provided. | 1992 | Mountain View, California, United States | USD 20 M | USD 1.18 B | 3,670 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Orbitalrx
Complete news archive for OrbitalRX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OrbitalRX
OrbitalRX was founded in 2017 and raised its 1st funding round 2 years after it was founded.
OrbitalRX is headquartered in Winston-salem, United States. It is registered at Winston-salem, North Carolina, United States.
OrbitalRX is a funded company, having raised a total of $5.89M across 6 funding rounds to date. The company's 1st funding round was a Seed of $2.15M, raised on Aug 2019.
OrbitalRX (previously known as Arxchitect) provides drug shortage management solutions. It provides tools to hospitals and pharmacies to address medication shortages and responding to supply chain threats. The platform allows the users to access drug information such as the drug stock in the inventory, automated storage inventory, and customizable labeling solutions. The inbuilt dashboard provides access to the information of the inventory and also assists with the communication system.
OrbitalRX offers Shortage Manager, ShortScore, and OrbitalRX Platform.
OrbitalRX has 1 investor. Key investors include The Launch Place.